Certolizumab pegol is a treatment for psoriatic arthritis, a medicine that blocks a protein called tumour necrosis factor alpha (TNF-a) and helps to…
The challenges of living with psoriatic arthritis are widespread; just managing the physical symptoms of pain and fatigue are both difficult, add to…
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. 'Evidence…
The Department of Health is seeking views on how local authorities should deliver the care and support reforms in the 2014 Care Act. The department is asking for views on the draft regulations and guidance for Part 1 of the 2014 Care Act.
Have you found the thought of reading research reports daunting; or get lost in the medical jargon?
Do you have psoriasis and or psoriatic arthritis? Would you like to help with research? Do you want to have your say about what is important to you?
People, who live with a chronic disease, have a unique insight into the issues that are important to managing their condition. We would like to…
University of Hull investigators Dr Henning Holle (Principal Investigator), Dr Fiona Cowdell (Co-Investigator), Mrs Samantha Swithenbank (Research Assistant) are carrying out an online research study called: Auditory modulation of itch in people with psoriasis: an online study.
The International Federation of Psoriasis Associations (IFPA), the International League of Dermatological Societies (ILDS) and the International…
The Scottish Medicines Consortium (SMC) has accepted ustekinumab for use in patients with active psoriatic arthritis who have failed on, or are …